The result has been an explosion in demand, with roughly 40 million Americans having tried a GLP-1 for weight loss, according to a 2026 RAND report
According to the company's FAQ, FDA-approved GLP-1/GIP medications including Ozempic, Wegovy, Zepbound, and Mounjaro "may also be eligible for coverage," and the company states it assists with prior authorizations and prescription submissions for these medications
Diabetes 1996
Some people have taken unofficial versions regardless, drawn by the promise of rapid weight loss, and it is largely from this group that reports of shedding have surfaced
This year, its called From New to Normal
Cancer risk: Increases cancer risk by 50% compared to people with healthy weight